ECP treatment for stable angina while waiting for heart care
Part of Heart & circulation, Pain clinical trials.
This trial studies whether ECP (a non-surgical treatment that improves blood flow to the heart) can reduce symptoms in people with stable angina who may need or are waiting for heart bypass surgery, or are being managed with medicines instead. It may help you feel better and need less urgent care—if you meet the study’s medical and personal requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have diagnosed stable angina (chest pain that is predictable with activity, not sudden)
- Have specific heart artery blockage patterns (2-vessel or 3-vessel disease) and be a CABG (bypass) candidate or choosing medical treatment because surgery risk is high
- Not be planning an urgent bypass surgery, and have started your best heart medicines within the last 2 weeks
- Live in Bandung City (or nearby) and be able and willing to follow study visits and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called EECP (which uses gentle pressure on your legs to help your heart) to see if it can reduce inflammation and protect your organs during heart surgery. It might help you recover better after the operation.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial studies people who have chest pain (angina) due to problems with the heart’s small arteries, not a big blockage. It aims to test whether treatment approaches can help these patients by better understanding the cause of their heart-related symptoms.
This study compares two types of temporary heart pumps used during a high-risk angioplasty (a procedure to open blocked heart arteries). It aims to see which one provides better support for patients with weak hearts, potentially leading to safer outcomes.
This trial compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stents (PCI)—in people whose heart pumps weakly (LVEF 40% or less). It aims to find which method works better for chest pain or recent heart issues.
This trial tests a drug called EA-230 that may help people recover faster after heart bypass surgery. If you are having planned bypass surgery, this drug might shorten your hospital stay.
Hear when a new Angina Pectoris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.